Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Can a personalized exercise plan boost heart rehab for seniors?

NCT ID NCT05925634

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing This study
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Aug 04, 2026 · Last updated Aug 05, 2026 · Updated 1 time

Summary

This trial tests whether a personalized exercise prescription, based on a graded exercise test and target heart rate, improves fitness more than standard perceived exertion-based exercise in older adults (60+) recovering from heart events like heart attacks or heart surgery. Participants will be randomly assigned to one of two exercise groups and attend at least 18 cardiac rehab sessions. The study measures changes in walking ability, strength, and balance, and also explores how psychological feedback affects exercise habits and long-term outcomes.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Personalized exercise prescription based on a graded exercise test and target heart rate range, compared to standard perceived exertion-based exercise
What this could lead to
If personalized exercise prescriptions improve fitness more than standard methods, this could lead to better cardiac rehab outcomes for older adults, potentially reducing future heart problems.
What could go wrong
This is a behavioral intervention, and results may vary. The trial is not a cure and focuses on improving fitness; individual responses to exercise can differ, and long-term benefits are not guaranteed.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 320 people

The number the study aims to enrol. It can still change while the study runs.

Started

Aug 2023

Expected to finish

Jun 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

60 to 99 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Patients who are eligible for cardiac rehabilitation by having had a cardiac event such as a myocardial infarction (heart attack), heart failure, percutaneous coronary intervention or angioplasty with stent, coronary artery bypass graft, or heart valve surgery in the past 6 months. * Lives in, or plans to reside in, the Springfield, MA, or greater Detroit, MI, area for the next year. * Recruited from a Phase 2 Cardiac Rehabilitation Center at either Baystate Medical Center or Henry Ford Health System. * Age ≥ 60 years * Agrees to attend at least 18 sessions of cardiac rehabilitation after randomization * Agrees to attend cardiac rehabilitation at least twice a week Exclusion Criteria: These include conditions that alter the physiology and monitoring of resting and exercise heart rate. These also include conditions that might limit an individual's ability to exercise. * Permanent atrial fibrillation * Heart transplant * Left-ventricular assist devices * Stable angina * High-risk un-revascularized coronary artery disease * Symptomatic peripheral artery disease * Aortic and/or mitral stenosis * Any condition where exercise testing or training might be unsafe or limited

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Cardiac valve surgery are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Baystate Medical Center

    Springfield, Massachusetts, 01199, United States

  • Henry Ford Health System

    Detroit, Michigan, 48202, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.